FastWave Medical has secured its eighth US patent for its electric intravascular lithotripsy (E-IVL) platform, Artero, reflecting the company’s continued innovation in developing next-generation solutions for peripheral arterial disease (PAD) treatment, the company reports in a press release.
“IVL has become one of my frontline tools for treating peripheral arterial disease—it’s one of the most exciting breakthroughs we’ve seen in years,” said Constantino Pena (Miami, USA), a diagnostic and interventional radiologist at Baptist Health South Florida. “Watching companies like FastWave push the envelope and bring fresh ideas to IVL technology makes this an incredible time to be in the field. The pace of innovation is truly inspiring, and it’s patients who stand to benefit most.”
The Artero system is designed to “streamline” PAD treatment with a simplified interface that delivers circumferential sonic pressure waves at 4Hz—twice the speed of existing IVL devices, according to the company.
“Too many medical devices are designed behind closed doors with limited user feedback. We wanted to flip that around and start with the daily frustrations physicians face and build from there,” said Scott Nelson, co-founder and CEO of FastWave Medical.
